Gb Sciences Inc financial data

Symbol
GBLX on OTC
Location
6450 Cameron Street #110 A, Las Vegas, NV
State of incorporation
NV
Fiscal year end
March 31
Former names
Growblox Sciences, Inc. (to 5/12/2017), Signature Exploration & Production Corp. (to 5/9/2014), Diabetic Treatment Centers of America, Inc. (to 3/6/2008), FLAGSTICK VENTURES INC (to 8/5/2004)
Latest financial report
10-Q - Q3 2024 - Nov 27, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.09 % -62.8%
Debt-to-equity -102 % +4.13%
Return On Equity 21 % -79.9%
Return On Assets -763 % -185%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 407M shares +1.08%
Common Stock, Shares, Outstanding 407M shares +1.08%
Entity Public Float 4M USD -64.6%
Common Stock, Value, Issued 40.8K USD +1.07%
Weighted Average Number of Shares Outstanding, Basic 407M shares +2.86%
Weighted Average Number of Shares Outstanding, Diluted 379M shares +10.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Cost of Revenue 0 USD
General and Administrative Expense 158K USD -71.4%
Operating Income (Loss) -1.02M USD +42.1%
Nonoperating Income (Expense) -114K USD +95%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.13M USD +71.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -1.13M USD +71.9%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.32K USD -97.8%
Assets, Current 93.8K USD -60%
Property, Plant and Equipment, Net 0 USD -100%
Assets 103K USD -70.6%
Accounts Payable, Current 1.75M USD +0.92%
Accrued Liabilities, Current 113K USD +48.8%
Liabilities, Current 5.44M USD +12.1%
Liabilities 5.87M USD +19.2%
Retained Earnings (Accumulated Deficit) -111M USD -1.03%
Stockholders' Equity Attributable to Parent -5.78M USD -23.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -5.78M USD -23.2%
Liabilities and Equity 93.8K USD -60%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22K USD +79.1%
Net Cash Provided by (Used in) Financing Activities 10K USD -60%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 950M shares 0%
Common Stock, Shares, Issued 407M shares +1.08%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -12K USD +85.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 110K USD -53%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 14.1M USD -2.97%
Deferred Tax Assets, Gross 14.1M USD -2.97%
Deferred Tax Assets, Operating Loss Carryforwards 11.1M USD +1.14%
Additional Paid in Capital 105M USD +0.04%
Amortization of Intangible Assets 0 USD -100%
Interest Expense 183K USD -32.7%